                         SEQUENCE LISTING

<110>  Convoy Therapeutics
       The Regents of the University of California
       Muraski, John A. Jr.
       Mitragotri, Samir
       Chen, Ming
 
<120>  SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF
        USE THEREFOR

<130>  1861/5 PCT

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  1

Thr Gly Ser Thr Gln His Gln 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  2

His Ser Ala Leu Thr Lys His 
1               5           


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  3

Lys Thr Gly Ser His Asn Gln 
1               5           


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  4

Met Gly Pro Ser Ser Met Leu 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  5

Thr Asp Pro Asn Gln Leu Gln 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  6

Ser Thr His Phe Ile Asp Thr 
1               5           


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  7

Cys Thr Gly Ser Thr Gln His Gln Cys 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  8

Cys His Ser Ala Leu Thr Lys His Cys 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  9

Cys Lys Thr Gly Ser His Asn Gln Cys 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  10

Cys Met Gly Pro Ser Ser Met Leu Cys 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  11

Cys Thr Asp Pro Asn Gln Leu Gln Cys 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  12

Cys Ser Thr His Phe Ile Asp Thr Cys 
1               5                   


<210>  13
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  13

Ala Cys Thr Gly Ser Thr Gln His Gln Cys Gly 
1               5                   10      


<210>  14
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  14

Ala Cys His Ser Ala Leu Thr Lys His Cys Gly 
1               5                   10      


<210>  15
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  15

Ala Cys Lys Thr Gly Ser His Asn Gln Cys Gly 
1               5                   10      


<210>  16
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  16

Ala Cys Met Gly Pro Ser Ser Met Leu Cys Gly 
1               5                   10      


<210>  17
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  17

Ala Cys Thr Asp Pro Asn Gln Leu Gln Cys Gly 
1               5                   10      


<210>  18
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized peptide

<400>  18

Ala Cys Ser Thr His Phe Ile Asp Thr Cys Gly 
1               5                   10      


<210>  19
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Artificially synthesized ribooligonucleotide

<400>  19
gacguaaacg gccacaaguu c                                                 21


